-
EnWave Reports 2025 Fourth Quarter and Annual 2025 Consolidated Financial Results
15 Dec 2025 14:00 GMT
… financial results for the fourth quarter and fiscal year … Significant Corporate Accomplishments in Q4 2025 and Subsequently:
… for the food, pharmaceutical and cannabis industries that … , market position, expected expenditures, and the expected synergies …
-
InMed Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update
19 Dec 2025 17:29 GMT
… President, InMed Pharmaceuticals Inc. (Credit: InMed Pharmaceuticals)
Eric A … fourth quarter of calendar year 2026."
Business Update - Pharmaceutical … and capital expenditure into the fourth quarter of … InMed
InMed Pharmaceuticals is a pharmaceutical drug …
-
Genital Dysfunction Drugs Market is expected to reach US$ 7.16 billion by 2031 | DataM Intelligence
19 Dec 2025 09:32 GMT
… policies, and robust pharmaceutical manufacturing activities. Rising … standpoint, hospital pharmacies and retail pharmacies remain the … . Pharmaceutical research advancements, increased R&D expenditure, … FDA decisions in Q4, including potential approvals …
-
Eurosystem staff macroeconomic projections for the euro area, December 2025
18 Dec 2025 19:41 GMT
… increase modestly in the fourth quarter, amid continued divergence … decomposition into the main expenditure components
a) December 2025 … reflected specificities of the pharmaceuticals supply chain, amid … 2.5% in the fourth quarter, reflecting the recent …
-
Drug Delivery Devices Market Set to Exceed US$ 450.7 Billion by 2035 as Biologic Revenue Surges Drive Urgent Expansion of Device Manufacturing Capacity Says Astute Analytica
18 Dec 2025 00:54 GMT
… 43 billion in fourth-quarter revenue alone. These … Pharmaceutical Services reported US$ 377 million in 2024 capital expenditures … Q4 2024 specifically to project timing and inventory adjustments by pharmaceutical … 40% in the fourth quarter. Record quarterly …
-
<![CDATA[Soaring off the Patent Cliff: Preparing for the Next Wave of Oncology Biosimilars]]>
17 Dec 2025 17:52 GMT
… significantly reducing treatment expenditures.1,2 These … for pharmacy practice are significant. Pharmacists will need … www.ipdanalytics.com
Biomedtracker Pharma Intelligence, Citeline Commercial, … Bristol Myers Squibb reports fourth quarter and full-year …
-
Intranasal Drug Delivery Market is expected to reach US$ 20.7 billion by 2031 | DataM Intelligence
17 Dec 2025 11:54 GMT
… healthcare expenditure, and strong government investment in pharmaceutical development … products. Retail pharmacies and online platforms … fastest growth. Expanding pharmaceutical manufacturing, growing … Alfresa Holdings planning a Q4 launch.
Unlock 360 …
-
Trade Shifts
16 Dec 2025 14:16 GMT
… $15 billion in contracted capital expenditure while the power sector will … ,” Bolwijn says, adding that the fourth quarter could see an uptick in … .
“I’ve spoken with some pharma companies who took a wait …
-
DAVIDsTEA Reports Third Quarter Results
16 Dec 2025 12:00 GMT
… and the seasonally stronger fourth quarter, and we continue … enter the revenue-intensive fourth quarter, early retail trends have … of payroll, ongoing technology expenditures and other operating costs. … 000 grocery stores and pharmacies, over 1,500 convenience …
-
Abivax Presents Third Quarter 2025 Financial Results
15 Dec 2025 21:07 GMT
… a cash runway into Q4 2027
PARIS, France, … flow requirements into the fourth quarter of 2027. ***** About … operating expenses and capital expenditure requirements. Special consideration … the assessment of preclinical, pharmacokinetic, carcinogenicity, toxicity, …